SPL (ASX:SPL) Announces Preliminary Financial Report
Financial Performance
SPL reported revenue of $4.912 million for the year ended 30 June 2025, a 41% decrease from $8.289 million the previous year. The loss for the period attributable to members increased by 22% to $9.990 million, compared to $8.165 million in the prior year.
Operating Result
Adjusted revenue, excluding the Mundipharma settlement, surged by 183% to $4.912 million from $1.735 million. Adjusted loss, excluding the settlement, decreased by 32% to $9.990 million from $14.718 million. The loss includes $8.355 million in research and product development expenses, net of the Australian Government’s R&D tax incentive.
Dividend Declaration
No dividends were paid or declared during the current period or the previous corresponding period.
Motley Fool contributor Lianne Eastty has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
